These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 17639776)

  • 1. Get shrunk at your own risk.
    Begley S
    Newsweek; 2007 Jun; 149(25):49. PubMed ID: 17639776
    [No Abstract]   [Full Text] [Related]  

  • 2. Counselling: indications and results.
    Cramer D
    Br J Hosp Med; 1993 Sep 15-Oct 5; 50(6):333-6. PubMed ID: 8242217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Psychotherapy should be verifiable too].
    Müller-Oerlinghausen B
    MMW Fortschr Med; 2011 Sep; 153(39):30. PubMed ID: 21991832
    [No Abstract]   [Full Text] [Related]  

  • 4. Assessing abuse liability during drug development: changing standards and expectations.
    Schoedel KA; Sellers EM
    Clin Pharmacol Ther; 2008 Apr; 83(4):622-6. PubMed ID: 18212799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Iatrogenic disease in the elderly.
    Smyth JT
    Aust Fam Physician; 1982 Oct; 11(10):785-8. PubMed ID: 7181747
    [No Abstract]   [Full Text] [Related]  

  • 6. [On the crossroads of iatropsychogenic and liberating psychotherapy].
    Schipkowensky N
    Cesk Psychiatr; 1970 Apr; 66(2):78-83. PubMed ID: 5444519
    [No Abstract]   [Full Text] [Related]  

  • 7. Risk evaluation and mitigation strategies for drugs with abuse liability: public interest, special interest, conflicts of interest, and the industry perspective.
    Wright C; Schnoll S; Bernstein D
    Ann N Y Acad Sci; 2008 Oct; 1141():284-303. PubMed ID: 18991964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Model-based benefit-risk assessment: can Archimedes help?
    Krishna R
    Clin Pharmacol Ther; 2009 Mar; 85(3):239-40. PubMed ID: 19223878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk drinking behavior among psychotropic drug users in an aging Finnish population: the FinDrink study.
    Ilomäki J; Korhonen MJ; Enlund H; Hartzema AG; Kauhanen J
    Alcohol; 2008 Jun; 42(4):261-7. PubMed ID: 18400450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmaceuticals & psychotropic drugs.
    Health Aff (Millwood); 2009; 28(3):723. PubMed ID: 19414880
    [No Abstract]   [Full Text] [Related]  

  • 11. Hormesis, non-linearity, and risk communication.
    Calabrese E
    Hum Exp Toxicol; 2009 Jan; 28(1):5-6. PubMed ID: 19411553
    [No Abstract]   [Full Text] [Related]  

  • 12. Quantitative decision analysis: a work in progress.
    Temple R
    Clin Pharmacol Ther; 2007 Aug; 82(2):127-30. PubMed ID: 17632535
    [No Abstract]   [Full Text] [Related]  

  • 13. The Counseling Evaluation Inventory and the Counselor Rating Form: their relationship to perceived improvement and to each other.
    Bachelor A
    Psychol Rep; 1987 Oct; 61(2):567-75. PubMed ID: 3432489
    [No Abstract]   [Full Text] [Related]  

  • 14. Thank you, FDA!
    Felton DA
    J Prosthodont; 2009 Oct; 18(7):549. PubMed ID: 19793327
    [No Abstract]   [Full Text] [Related]  

  • 15. Psychotropic drug use during breastfeeding: a review of the evidence.
    Fortinguerra F; Clavenna A; Bonati M
    Pediatrics; 2009 Oct; 124(4):e547-56. PubMed ID: 19736267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Foodborne and microbial toxins, part I: Chemical contamination and additives. Foreword.
    Smith MA; Rolston RK
    Dis Mon; 2009 May; 55(5):261-2. PubMed ID: 19362175
    [No Abstract]   [Full Text] [Related]  

  • 17. Genetically engineered animals in the food supply.
    Burns K
    J Am Vet Med Assoc; 2008 Nov; 233(9):1370-3. PubMed ID: 18980485
    [No Abstract]   [Full Text] [Related]  

  • 18. FDA on transgenic animals--a dog's breakfast?
    Miller HI
    Nat Biotechnol; 2008 Feb; 26(2):159-60. PubMed ID: 18259164
    [No Abstract]   [Full Text] [Related]  

  • 19. The risk we bear: the effects of review speed and industry user fees on new drug safety.
    Olson MK
    J Health Econ; 2008 Mar; 27(2):175-200. PubMed ID: 18207263
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FDA's device inspection lacking. Two reports point to technology, staffing as key culprits.
    Rhea S
    Mod Healthc; 2008 Feb; 38(5):10-1. PubMed ID: 18318369
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.